Investigational Drug Details
| Drug ID: | D528 |
| Drug Name: | Candesartan |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB13919 |
| DrugBank Description: | Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is available as a prodrug in the form of [Candesartan cilexetil]. |
| PubChem ID: | 2541 |
| CasNo: | 139481-59-7 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1 |
| Structure: |
|
| InChiKey: | HTQMVQVXFRQIKW-UHFFFAOYSA-N |
| Molecular Weight: | 440.454 |
| DrugBank Targets: | Type-1 angiotensin II receptor |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L1518 | NCT02228408 | PHASE4 | COMPLETED | YES | 2017-08-28 | 2021-04-27 | Details |
| L1568 | NCT00563342 | PHASE2 | TERMINATED | NO | 2007-06 | 2008-10-08 | Details |
| L2319 | NCT00318422 | PHASE3 | COMPLETED | NO | 2006-05 | 2017-01-25 | Details |
| L2344 | NCT00094757 | PHASE3 | COMPLETED | YES | 2004-10-06 | 2019-05-30 | Details |
| L5323 | NCT01751399 | PHASE1 | COMPLETED | YES | 2012-12 | 2018-10-19 | Details |
| L6780 | NCT01510847 | PHASE4 | TERMINATED | NO | 2011-10 | 2016-01-06 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|